These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 20851366

  • 1. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N.
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [Abstract] [Full Text] [Related]

  • 2. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
    J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE, Sawatari Y, Fortin M, Broumand V.
    J Oral Maxillofac Surg; 2005 Nov 01; 63(11):1567-75. PubMed ID: 16243172
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.
    Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF.
    Ann N Y Acad Sci; 2011 Feb 01; 1218():47-54. PubMed ID: 20946574
    [Abstract] [Full Text] [Related]

  • 5. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug 01; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 6. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH, Seal B, Tangirala M, Jeffcoat MK, Watts NB, Hay JW.
    Gen Dent; 2010 Aug 01; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bisphosphonate induced osteonecrosis of the jaw masquerading as tumor: a word of caution for oral surgeons and oncologists.
    Chaturvedi P, Pai PS, Chaukar DA, Gupta S, D'cruz AK.
    Eur J Surg Oncol; 2010 Jun 01; 36(6):541-5. PubMed ID: 20071132
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K.
    Expert Rev Anticancer Ther; 2009 Aug 01; 9(8):1125-34. PubMed ID: 19671032
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J, George T, Sandow P, Machado M, Dickerson L, Moreb JS.
    J Support Oncol; 2009 Aug 01; 7(1):9-10. PubMed ID: 19278171
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R.
    Dtsch Med Wochenschr; 2011 Oct 01; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract] [Full Text] [Related]

  • 17. Imaging findings of bisphosphonate-related osteonecrosis of the jaw with emphasis on early magnetic resonance imaging findings.
    Krishnan A, Arslanoglu A, Yildirm N, Silbergleit R, Aygun N.
    J Comput Assist Tomogr; 2009 Oct 01; 33(2):298-304. PubMed ID: 19346864
    [Abstract] [Full Text] [Related]

  • 18. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.
    Bagan J, Scully C, Sabater V, Jimenez Y.
    Oral Oncol; 2009 Jul 01; 45(7):551-4. PubMed ID: 19251474
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.